Minimal residual disease assessment of papillary thyroid carcinoma through circulating tumor cell‐based cytology

Abstract

Abstract The overall estimated risk of recurrence after an apparently complete thyroid cancer resection ranges from 5% CTCs (p = 0.09) and with >30% S‐phase cells at baseline (p = 0.0015), predicting ≤1 year relapsing lesion event. These results suggest a new intriguing frontier of precision oncology forefront cytology‐based liquid biopsy.

Keywords

• circulating tumor cells
• cytology CTCs
• Liquid biopsy
• PTC
• recurrence risk
• short‐time cultured CTCs